More News

30 Sep 2023 Novartis completes divestment of ‘front of eye’ ophthalmology assets
28 Sep 2023 Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's disease
27 Sep 2023 Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
26 Sep 2023 Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
20 Sep 2023 Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
20 Sep 2023 Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
19 Sep 2023 Pharmanovia acquires global central nervous system (CNS) portfolio from Sanofi
12 Sep 2023 Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer
12 Sep 2023 Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform
11 Sep 2023 Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium
09 Sep 2023 Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
05 Sep 2023 XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
01 Sep 2023 Otsuka Pharmaceutical to Acquire Mindset Pharma
01 Sep 2023 Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases.
31 Aug 2023 Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
29 Aug 2023 Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers
29 Aug 2023 Deargen and Serengen Partner to Accelerate Drug Discovery
23 Aug 2023 Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
22 Aug 2023 LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
16 Aug 2023 Chiesi Global Rare Diseases Announces Co-Development Agreement with Aliada Therapeutics to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
16 Aug 2023 Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
15 Aug 2023 Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
12 Aug 2023 HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells
11 Aug 2023 Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
11 Aug 2023 Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up